Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $44.7500 (-3.97%) ($44.7500 - $44.7500) on Tue. Jan. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 56 | Latest Price | $44.7500(-3.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.6% a day on average for past five trading days. | Weekly Trend | IOVA declines -1.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(44%) ARKG(43%) IWO(42%) ARKK(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.445% in a week (0% probabilities). VIXM(-24%) UUP(-16%) VXX(-12%) TBT(-6%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $48.43 | 5 Day Moving Average | $47.13(-5.05%) | 10 Day Moving Average | $48.82(-8.34%) | 20 Day Moving Average | $48.43(-7.6%) | To recent high | -13.5% | To recent low | 26% | Market Cap | $6.553b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |